Robert, Marie <br/><br/>
Olaparib for the treatment of breast cancer.  [electronic resource] 

 -  Expert opinion on investigational drugs  Jun 2017 
 - 751-759 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1744-7658 
<br/><br/><label>Standard No.: </label>10.1080/13543784.2017.1318847  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>BRCA1 Protein--genetics<br/>BRCA2 Protein--genetics<br/>Biomarkers, Tumor--metabolism<br/>Breast Neoplasms--drug therapy<br/>Drug Resistance, Neoplasm<br/>Female<br/>Humans<br/>Mutation<br/>Phthalazines--pharmacology<br/>Piperazines--pharmacology<br/>Poly(ADP-ribose) Polymerase Inhibitors--pharmacology